REFERENCES
- Keane WF, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, Kawaguchi Y, Piraino B, Riella M, Van S. International Society for Perioneal Dialysis. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int 2000; 20: 396–411, [PUBMED], [INFOTRIEVE]
- al-Zahawi MF Sprott MS, Hendrick DJ. Hallucinations in association with ceftazidime. Br Med J 1988; 297: 858
- Douglas MA, Quandt CM, Stanley DR. Ceftazidime-induced encephalopathy in a patient with renal impairment. Arch Neurol 1988; 45: 936–937, [INFOTRIEVE]
- Hillsley RE, Massey EW. Truncal asterisxis associated with ceftazidime, a third-generation cephalosporin. Neurology 1991; 41: 2008, [INFOTRIEVE]
- Jackson GD, Berkovic SF. Ceftazidime encephalopathy: absence status and toxic hallucinations. J Neurol Neurosurg Psychiatry 1992; 55: 333–334, [INFOTRIEVE]
- Lye WC, Leong SO. Neurotoxicity associated with intraperitoneal ceftazidime therapy in a CAPD patient. Perit Dial Int 1994; 14: 408–409, [INFOTRIEVE]
- Klion AD, Kallsen J, Cowl CT, Nauseef WM. Ceftazidime-related nonconvulsive status epilepticus. Arch Intern Med 1994; 154: 586–589, [INFOTRIEVE], [CROSSREF]
- Martinez-Rodriguez JE, Barriga FJ, Santamaria J, Iranzo A, Pareje JA, Revilla M, dela Rosa CR. Nonconvulsive status epilepticus associated with cephalosporins in patients with renal failure. Am J Med 2001; 111: 115–119, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Chow KM, Wang AY, Hui AC, Wong TY, Szeto CC, Li PK. Nonconvulsive status epilepticus in peritoneal dialysis patients. Am J Kidney Dis 2001; 38: 400–405, [PUBMED], [INFOTRIEVE]
- Chow KM, Szeto CC, Hui AC, Li PK, Wong TY. Retrospective review of neurotoxicity induced by cefepime and ceftazidime. Pharmacotherapy 2003; 23: 369–373, [INFOTRIEVE], [CROSSREF]
- Chuang CL, Chen KP, Kwan SY, Yang WC. Creutzfeldt-Jakob-like EEG in a patient with end-stage renal failure. Nephrol Dial Transplant 2004; 19: 252–254, [INFOTRIEVE], [CROSSREF]
- Primavera A, Cocito L, Audenino D. Nonconvulsive status epilepticus during cephalosporin therapy. Neuropsychobiology 2004; 49: 218–222, [INFOTRIEVE], [CROSSREF]
- Kaplan PW. Nonconvulsive status epilepticus. Neurology 2003; 61: 1035–1036, [PUBMED], [INFOTRIEVE]
- Towne AR, Waterhouse EJ, Boggs JG, Garnett LK, Brown AJ, Smith JR, JrDeLorenz RJ. Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology 2000; 54: 340–345, [PUBMED], [INFOTRIEVE]
- Walker MC. Diagnosis and treatment of nonconvulsive status epilepticus. CNS Drugs 2001; 15: 931–939, [INFOTRIEVE], [CROSSREF]
- De Deyn PP Macdonald RL. Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture. Ann of Neurol 1990; 28: 627–633, [CROSSREF]
- De Deyn PP Marescau B, D’Hooge R, Possemiers I, Nagler J, Mahler C. Guanidino compound levels in brain regions of non-dialyzed uremic patients. Neurochem Int 1995; 27: 227–237, [INFOTRIEVE], [CROSSREF]
- Smogorzewski MJ. Central nervous dysfunction in uremia. Am J Kidney Dis 2001; 38: 122–128
- Curtis DR, Game CJ, Johnston GA, McCulloch RM, MacLachlan RM. Convulsive action of penicillin. Brain Res 1972; 43: 242–245, [INFOTRIEVE], [CROSSREF]
- Wallace KL. Antibiotic-induced convulsion. Crit Care Clin 1997; 13: 741–762, [INFOTRIEVE], [CROSSREF]
- Chow KM, Szeto CC, Hui AC, Li PK. Mechanisms of antibiotic neurotoxicity in renal failure. Int J Antimicrob Agents 2004; 23: 213–217, [INFOTRIEVE], [CROSSREF]
- Grabe DW, Bailie GR, Eisele G, Frye RF. Pharmacokinetics of intermittent intraperitoneal ceftazidime. Am J Kidney Dis 1999; 33: 111–117, [INFOTRIEVE]
- McIntosh ME, Smith WG, Junor BJ, Forrest G, Brodie MJ. Increased peritoneal permeability in patients with peritonitis undergoing continuous ambulatory peritoneal dialysis. Eur J Clin Pharmacol 1985; 28: 187–191, [INFOTRIEVE], [CROSSREF]
- Leroy A, Leguy F, Borsa F, Spencer GR, Fillastre JP, Humbert G. Pharmacokinetics of ceftazidime in normal and uremic subjects. Antimicrob Agents Chemother 1984; 25: 638–642, [INFOTRIEVE]
- Demotes-Mainard F, Vincon G, Ragnaud JM, Morlat P, Bannwarth B, Dangoumau J. Pharmacokinetics of intravenous and intraperitoneal ceftazidime in chronic ambulatory peritoneal dialysis. J Clin Pharmacol 1993; 33: 475–479, [INFOTRIEVE]
- Nikolaidis P, Tourkantonis A. Effect of hemodialysis on ceftazidime pharmacokinetics. Clin Nephrol 1985; 24: 142–146, [INFOTRIEVE]